Maternal and fetal healthcare
70 та иш
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan
Sheila Raghavan, Tamar Tsereteli, A. Kamilov +5
МақолаReproductive Health and ContraceptionThe European Journal of Contraception & Reproductive Health Care20130 иқтибосABICURRENT STATE OF THE PROBLEM OF SOFT TISSUES RUPTURE DURING VAGINAL BIRTH IN WOMEN WITH DIABETES AND GESTATIONAL MELLITUS
Zufarova Shakhnoza Alimjanovna, Kholmatova Shirin Shukhrat Qizi, Kamalov Telman Tulaganovich
МақолаCardiovascular Issues in PregnancyInternational Journal of Medical Sciences And Clinical Research20220 иқтибосABI